期刊文献+

IκBα突变体基因修饰树突状细胞降低同种T细胞的反应性 被引量:3

Immune tolerance of allogeneic T cells induced by dendritic cells genetically en gineered to express IκBα mutant
原文传递
导出
摘要 目的观察IκBα突变体基因修饰的树突状细胞(IκBαM-DC)对同种T细胞的反应性。方法利用腺病毒载体将IκBαM基因转染WF大鼠骨髓树突状细胞(DC),Western-blot法检测DC中IκBα、IκBαM基因的表达;用流式细胞仪检测DC中共刺激分子MHCⅡ、CD80、CD86、CD40的表达;酶联免疫法(ELISA)分析DC分泌IL-12的含量。通过混合淋巴细胞反应(MLR)分析Lewis大鼠T细胞对IκBαM-DC刺激的增殖能力,二次MLR检测IκBαM-DC诱导的T细胞抗原特异性的低反应性。结果IκBαM抑制DC共刺激分子MHCⅡ、CD80、CD86、CD40的表达及IL-12分泌。同种T细胞对IκBαM-DC刺激的增殖能力较未转染的DC反应明显降低;T细胞低反应具有抗原特异性。结论表达IκBα突变体基因的DC能降低同种T细胞的反应性。 Objective To assess the immune tolerance of allogeneic T cells induced by dendritic cells genetically engineered to express IκBα mutant. Methods DCs were prepared from WF rat bone marrow cells and modified by IκBαM gene with adenovirus vector, and then the expression of IκBα and IκBαM was detected by Western-blot. The cell-surface expression of costimulatory molecules (CD80, CD86 and CD40) was detected by flow cytometry, and the production of IL-12 in DCs culture supermatant was determined by ELISA. The ability to stimulate the proliferation of Lewis rat T cells was analyzed by mixed leukocyte reactions (MLR). The antigen-specific T cell hyporesponsiveness was tested by secondary MLR. Results IκBαM suppressed the cell-surface expression of costimulatory molecules and inhibited the production of IL 12. IκBαM-DC showed reduced ability to stimulate T cell sproliferation, and potential to induce antigen-specific T cell hyporesponsiveness. Conclusion Immune tolerance of T cells can be induced by dendritic cells genetically engineered to express IκBα mutant.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第8期490-493,共4页 Chinese Journal of Organ Transplantation
基金 武汉大学人才专项基金资助项目(502273106)
关键词 基因 树突状细胞 T淋巴细胞 免疫耐受 Gene Dendritic cells T-Lymphocytes Immune tolerance
  • 相关文献

参考文献10

  • 1张工梁 郑素琴 等.分离T、B淋巴细胞的简易方法[J].上海免疫学杂志,1986,6(3):184-184.
  • 2Jonuleit H, Schmitt E, Steinbrink K, et al. Dendritic cells as a tool to induce anergic and regulatooy T cells. Trends Immunology, 200I, 22: 394-400.
  • 3Morel PA, Feili-Hariri M, Coates PT, et al, Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol, 2003, 133 : 1-10.
  • 4Cruz MT, Duarte CB, Goncalo M, et al. Differential activation of nuclear factor kappa B subunits in a skin dendritic cell line inresponse to the strong sensitizer 2,4-dinitrofluorobenzene. Arch Derrnatol Res, 2002, 294: 419-425.
  • 5Hackstein H, Morelli AE, Thomson AW. Densigner dendritic cells for tolerance induction: guided not misguided missiles.Trends Immunology, 2001, 22:437-442.
  • 6Coates PT, Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant, 2002, 2: 299-307.
  • 7Coates PT, Colvin BL, Kaneko K, et al. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation, 2003, 75(Suppl) : 32-36.
  • 8Neumann M, Fries HW, Scheicher C, et al. Differential expression of Rel/NF-кB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood, 2000, 95: 277-285.
  • 9Sato T, Odagiri H, Ikenaga SK, et al. Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor. Cancer Sci, 20()3, 94: 467-472.
  • 10Rusella S, Lemoli RIM. Regulatory T cells and tolerogenic dendritic cells: from basic biology so clinical applications. Immunol Lett, 2004, 94: 11-26.

共引文献7

同被引文献8

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部